Director Chell Jeffrey W. received 61,600 Actinium Pharmaceuticals shares at $0 per share. The transaction leaves him with 61,600 shares and 92,400 derivative securities, giving investors disclosed ownership figures for both Equity and derivative interests tied to the director.

Key Highlights

  • The award was recorded on September 2, 2026, under transaction code A.
  • Chell Jeffrey W. held 61,600 shares after the transaction.
  • His post-transaction holdings also included 92,400 derivative securities.

Director Chell Jeffrey W. was awarded 61,600 Actinium Pharmaceuticals, Inc. (AMEX: ATNM) shares at $0 per share.

Director Award Details The

transaction occurred on September 2, 2026, under SEC transaction code A. Chell Jeffrey W. held 61,600 Actinium Pharmaceuticals shares after the award. A separate award on the same date covered 92,400 derivative securities. His ownership following that transaction was 92,400 derivative securities. The disclosed awards cover both shares and derivative securities. The share award was priced at $0 per share.